Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Oral Contraceptives and the Risk of Ductal Breast Carcinoma in situ

Oral Contraceptives and the Risk of Ductal Breast Carcinoma in situ Recent evidence suggests that oral contraceptive use is associated with little to no increased risk of invasive breast carcinoma. No study has examined the relationship between oral contraceptive use and the risk of non-invasive breast carcinoma, that is, breast carcinoma in situ. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Breast Cancer Research and Treatment Springer Journals

Oral Contraceptives and the Risk of Ductal Breast Carcinoma in situ

Loading next page...
 
/lp/springer-journals/oral-contraceptives-and-the-risk-of-ductal-breast-carcinoma-in-situ-KmngrS3ShN

References (24)

Publisher
Springer Journals
Copyright
Copyright © 2003 by Kluwer Academic Publishers
Subject
Medicine & Public Health; Oncology
ISSN
0167-6806
eISSN
1573-7217
DOI
10.1023/A:1025728524310
pmid
14572155
Publisher site
See Article on Publisher Site

Abstract

Recent evidence suggests that oral contraceptive use is associated with little to no increased risk of invasive breast carcinoma. No study has examined the relationship between oral contraceptive use and the risk of non-invasive breast carcinoma, that is, breast carcinoma in situ.

Journal

Breast Cancer Research and TreatmentSpringer Journals

Published: Oct 17, 2004

There are no references for this article.